We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$14.2M
AG
2
Artal Group
Luxembourg
$12.9M
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$10.7M
SB
4
Samsara BioCapital
California
$9.22M
APM
5
Avidity Partners Management
Texas
$8.64M
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$7.59M
FP
7
Flagship Pioneering
Massachusetts
$6.68M
Vanguard Group
8
Vanguard Group
Pennsylvania
$5M +$211K +40,171 +4%
OM
9
Opaleye Management
Massachusetts
$4.47M +$409K +77,898 +10%
DTC
10
Deep Track Capital
Connecticut
$4.27M
KCM
11
Kennedy Capital Management
Missouri
$2.21M +$119K +22,622 +6%
BOCH
12
Blue Owl Capital Holdings
New York
$1.76M
Walleye Capital
13
Walleye Capital
New York
$1.47M +$4.56K +867 +0.3%
UOC
14
UBS O'Connor
Illinois
$1.44M +$542K +103,103 +59%
ECM
15
ExodusPoint Capital Management
New York
$1.36M +$571K +108,702 +70%
Goldman Sachs
16
Goldman Sachs
New York
$1.35M -$968K -184,218 -41%
BlackRock
17
BlackRock
New York
$1.34M +$11.3K +2,148 +0.8%
OFM
18
Omega Fund Management
Massachusetts
$1.3M
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.17M +$30.8K +5,865 +3%
Marshall Wace
20
Marshall Wace
United Kingdom
$828K +$4.24K +806 +0.5%
EAM
21
Exome Asset Management
New York
$821K +$836K +159,175 New
DCM
22
DAFNA Capital Management
California
$701K
Renaissance Technologies
23
Renaissance Technologies
New York
$606K -$12.6K -2,400 -2%
PA
24
Perceptive Advisors
New York
$602K
LPL Financial
25
LPL Financial
California
$395K +$2.63K +500 +0.7%